Roger D. Weiss, MD

Original Research

Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes

January 14, 2026

Even very low levels of opioid use in the first 2–3 weeks of buprenorphine treatment signal risk for poor outcomes.

Victoria R. Votaw, Allen J. Bailey, Roger D. Weiss, et al

Article

Opioid Abstinence Over 42-Month Follow-Up

March 26, 2019

Which treatments are strongly associated with opioid abstinence over time among patients with prescription opioid dependence: Opioid agonists? Outpatient counseling? Mutual-help group attendance?

Margaret L. Griffin, Roger D. Weiss, R. Kathryn McHugh, et al

Article

Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population

December 23, 2014

Margaret L. Griffin, Roger D. Weiss, Garrett M. Fitzmaurice, et al

Original Research

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

January 10, 2012

Margaret L. Griffin, Roger D. Weiss, Garrett M. Fitzmaurice, et al

Original Research

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

May 18, 2010

Lenard A. Adler, Roger D. Weiss, Theresa M. Winhusen, et al

Original Research

Depression Precipitated by Alcohol Use in Patients With Co-Occurring Bipolar and Substance Use Disorders

December 30, 2009

Margaret L. Griffin, Roger D. Weiss, Robert Gallop, et al

Original Research

Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance

November 17, 2009

Roger D. Weiss, Boaz Levy

Original Research

Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders

August 15, 2007

Sumita G. Manwani, Kathleen A. Szilagyi, Benjamin Zablotsky, et al

Original Research

The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder

December 15, 2006

Andrew A. Nierenberg, Roger D. Weiss, Gary S. Sachs, et al

Original Research

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

June 15, 2005

Joseph R. Calabrese, Andrew A. Nierenberg, Roger D. Weiss, et al

Original Research

Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem?

February 15, 2003

Roger D. Weiss, Harrison G. Pope, Jr., Gen Kanayama, et al

Original Research

Group Therapy for Patients With Bipolar Disorder and Substance Dependence: Results of a Pilot Study

October 31, 2000

Margaret L. Griffin, Roger D. Weiss, Shelly F. Greenfield, et al

Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes

Opioid Abstinence Over 42-Month Follow-Up

Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

Depression Precipitated by Alcohol Use in Patients With Co-Occurring Bipolar and Substance Use Disorders

Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance

Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders

The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem?

Group Therapy for Patients With Bipolar Disorder and Substance Dependence: Results of a Pilot Study

ELSEWHERE:

FOLLOW US:

Roger D. Weiss, MD

Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes

Opioid Abstinence Over 42-Month Follow-Up

Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

Depression Precipitated by Alcohol Use in Patients With Co-Occurring Bipolar and Substance Use Disorders

Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance

Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders

The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem?

Group Therapy for Patients With Bipolar Disorder and Substance Dependence: Results of a Pilot Study

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles